| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Electron transport chain oxphos system in mitochondria 0.6014816948446338 3.275019636493511 0.0010565462932874 0.4735835412751864 0.4015506981577424 54 O95139,P00846,P14406,Q7KZN9,P06576,P56385,O43676,Q9UII2,P13073,P18859,O75964,P51970,O14949,Q9UDW1,Q9Y6M9,P22695,P20674,P00403,P14927 19 |
| Mitochondrial complex iv assembly 0.7585046732577039 2.64556653104848 0.0081554247764432 0.9930612895788222 0.4266983671502216 13 Q9Y2R0,P13073,P14406,P20674,Q9Y241 5 |
| Proteasome degradation 0.5706366427163698 2.634348484334546 0.0084298918218432 0.994134302977966 0.4266983671502216 42 P10321,P28070,P60900,O00231,P28072,Q99436,P28074,P49721,Q9UL46,O43242,P51665,P61289,P25787,P62191,P20618 15 |
| Nonalcoholic fatty liver disease 0.5063692583298731 2.4189491941954877 0.0155654140609049 0.9999268143372932 0.4435446144315205 53 O95139,P13073,Q9P0J0,P14406,Q86Y39,Q9UDW1,P00403,Q9Y6M9,P22695,O43676,P20674,P51970,P14927,O14949 14 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5844740146226467 2.2740890033904493 0.0229606357353751 0.999999247301008 0.480589858323196 26 Q15800,Q15392,Q01581,Q14739,Q9BWD1,P37268,Q9UBM7 7 |
| Nucleotide excision repair 0.5896661224792253 2.2162232159465085 0.0266762186558888 0.9999999254921298 0.506014522628892 24 P54727,P41440,Q9NRF9,Q9NR33,P41208,P54725 6 |
| Cholesterol biosynthesis pathway 0.6544672020342218 2.1392201777500808 0.0324178407721189 0.9999999979463512 0.5194844924369614 14 Q15800,Q01581,P14324,O75845,P37268,Q9UBM7 6 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.674958796662934 2.093100873791615 0.0363401507373826 0.9999999998255282 0.5194844924369614 12 Q9NR77,Q15907 2 |
| Sphingolipid metabolism overview 0.7127883749854756 2.0798425595886756 0.0375399760080015 0.9999999999180972 0.5194844924369614 10 Q16880,Q16739,Q96G23,O95470,Q06136,P27544 6 |
| Sphingolipid metabolism integrated pathway 0.7127883749854756 2.0798425595886756 0.0375399760080015 0.9999999999180972 0.5194844924369614 10 Q16880,Q16739,Q96G23,O95470,Q06136,P27544 6 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6169335166209821 2.070827124057075 0.0383749544781608 0.9999999999516384 0.5194844924369614 17 O75844,O60725,P49354,P55209,P50402 5 |
| Influence of laminopathies on wnt signaling 0.6706953968572403 2.070589801741791 0.0383971460170078 0.9999999999523111 0.5194844924369614 12 O75844,P50402,P49354 3 |
| Mitochondrial complex iii assembly 0.7078443966637068 2.05546423449634 0.0398341867521114 0.9999999999807616 0.5194844924369614 10 Q9UDW1,Q6DKK2,P14927,O14949 4 |
| Sphingolipid metabolism in senescence 0.6421136610631631 2.027245205016889 0.0426373422144117 0.9999999999967384 0.5194844924369614 13 Q96G23,Q06136,P11802,Q16739 4 |
| Progeriaassociated lipodystrophy 0.6972120274490139 2.0028065391985 0.0451980577128341 0.9999999999993584 0.5194844924369614 10 O75844,P49354 2 |
| Metabolism of spingolipids in er and golgi apparatus 0.828743578245482 2.0014650396706832 0.0453422976771016 0.9999999999994144 0.5194844924369614 5 O95470,Q06136,Q16739 3 |
| Oxidative phosphorylation 0.5065528601546462 1.9844670365480608 0.047203799296243 0.9999999999998208 0.5194844924369614 34 O95139,P00846,P18859,Q86Y39,P56385,P06576,O75964,Q9Y6M9,P51970 9 |
| Cholesterol biosynthesis with skeletal dysplasias 0.7650117463430901 1.9792627318922384 0.04778643324989 0.9999999999998764 0.5194844924369614 7 Q15392,Q9UBM7,Q14739,O75845 4 |
| Nucleotide excision repair in xeroderma pigmentosum 0.5026402574984683 1.953727257987722 0.0507334809110024 0.9999999999999812 0.5194844924369614 34 P54727,P41440,Q9NRF9,P18074,Q9NR33,P41208,P54725 7 |
| Kennedy pathway from sphingolipids 0.8070753470089718 1.911097434677537 0.055992060771929 0.9999999999999992 0.5571668998124747 5 O95470,P35790,P49585 3 |
| Male infertility 0.5477768657709408 1.8960510468802825 0.0579532948353411 0.9999999999999998 0.5673444497433485 23 P17096,P41440,P18074,P40818,P08183,Q15165 6 |
| Proteoglycan biosynthesis 0.7371868241450446 1.8546650392727717 0.0636440741367176 1.0 0.5673444497433485 7 Q8TB61,Q9NX62,Q8NCH0 3 |
| Adipogenesis 0.5853868890841686 1.7889773317310245 0.0736184663119625 1.0 0.5770845647020617 15 P17096,O75844,P43490,Q9NZ45 4 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7765874158316923 1.7826314155601517 0.0746463224085554 1.0 0.5770845647020617 5 P49354 1 |
| Ccl18 signaling pathway 0.6515867510987416 1.7733304145163904 0.0761739720982996 1.0 0.5770845647020617 10 P00403,P08670,Q86UE4 3 |
| Hostpathogen interaction of human coronaviruses mapk signaling 0.7182274694637061 1.76886804877064 0.0769158973630443 1.0 0.5770845647020617 7 P27361,P36507,Q15418,P51812,Q16539 5 |
| Endothelin pathways 0.6924336029944866 1.7522325179092595 0.0797338342800937 1.0 0.5770845647020617 8 P42892,P00403,P16615,Q05682 4 |
| Translation factors 0.4728554420055349 1.740555239796781 0.0817615692988094 1.0 0.5770845647020617 36 O75821,Q14240,Q15056,P11940,P49770,P29692,O15372,Q9NR50,O75822,P55010,O75153,O00303,P60228,P23588 14 |
| Ketogenesis and ketolysis 0.6877049003742848 1.6293050911045606 0.1032484489389569 1.0 0.652831338603613 7 O43772 1 |
| Striated muscle contraction pathway 0.7386167146974025 1.6206580418094678 0.105090996860276 1.0 0.6573323449655891 5 P67936,P06753,P08670,O43707 4 |
| Cellular proteostasis 0.7368876080691601 1.6132346599359573 0.1066935360022551 1.0 0.6573323449655891 5 O15212,Q9NQP4,Q9UHV9,Q99471 4 |
| Familial partial lipodystrophy fpld 0.6585619154507728 1.5913059257537745 0.1115407438738973 1.0 0.6573323449655891 8 O75844,P49354 2 |
| Oxidation by cytochrome p450 0.7043241730489957 1.578147937330166 0.114531627542358 1.0 0.6684682492135703 6 Q6UW02,O43169,Q9UHQ9 3 |
| Sphingolipid pathway 0.6102850243066419 1.560940821868568 0.1185377143631467 1.0 0.6722519507289723 10 O95470,Q96G23,Q06136,Q16739 4 |
| Mevalonate pathway 0.688262024773372 1.5066884765131627 0.1318905266669627 1.0 0.6901512904038483 6 Q01581,Q9BWD1,P14324 3 |
| Ferroptosis 0.4802486560691383 1.4634410581582145 0.1433467308247187 1.0 0.6911233493884089 24 P02786,Q9UKU0,P45880,P09601,Q96FZ7,Q9NZ45,P37268,P04035 8 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.663334533807787 1.395160090462601 0.1629675689219158 1.0 0.7160248780487143 6 P09601 1 |
| Mitochondrial complex i assembly model oxphos system 0.4428429091249877 1.346256331347618 0.1782198637521423 1.0 0.7259987723253234 29 O43676,Q9P0J0,Q96CU9 3 |
| Vasopressinregulated water reabsorption 0.5054919415163535 1.3450569198825373 0.1786068538433651 1.0 0.7259987723253234 16 Q14203,Q15907,Q13409,Q13561,Q9Y6G9,Q9UJW0 6 |
| Egfegfr signaling pathway 0.4104577082768186 1.3199332386436684 0.1868573088557612 1.0 0.7382195636424966 44 Q92888,Q9P0J0,P36507,P00403,Q15418,P16949,P40818,P62993,P46108,P51812,Q16539,O15357 12 |
| Allograft rejection 0.5532356393020038 1.2615292043394566 0.207118244842769 1.0 0.752819009697969 10 Q9BY49,P08670,P08183 3 |
| Nanomaterial induced apoptosis 0.6012697481415168 1.2264427556403297 0.2200321047659597 1.0 0.771178294463815 7 O43464,Q9NR28 2 |
| Mfap5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement 0.6006882333531073 1.2237073625037482 0.221062641246629 1.0 0.771178294463815 7 P27361,P18206,P28482 3 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.562094854174209 1.211597999014761 0.2256663009106834 1.0 0.7821992644400032 9 P27361,P31943,P61020,O14964 4 |
| Aryl hydrocarbon receptor pathway wp2873 0.6904270286144882 1.1567917921889992 0.2473574360325068 1.0 0.8160106721289764 4 Q16543,P07900 2 |
| Myometrial relaxation and contraction pathways 0.4623356419451316 1.139013146596952 0.2546976709165922 1.0 0.8345540327734727 18 P61981,P16615,P63104,P0DP25,P62258,P78417,Q05682,P31946 8 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.6815840225569085 1.1204371248950025 0.2625275320255329 1.0 0.8345540327734727 4 P27361 1 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.4832885023189664 1.1118490453173089 0.2662030602451102 1.0 0.8345540327734727 13 O75821,P20042,O15372,O75822,P55010,P60228,O00303 7 |
| Dna mismatch repair 0.4512534557395721 1.0983072023872469 0.272070367953106 1.0 0.8414318080235993 19 Q9NR33,Q9NRF9 2 |
| Nad metabolism sirtuins and aging 0.6761759984512205 1.0982342805634484 0.2721022007560443 1.0 0.8414318080235993 4 P43490 1 |
| Nephrotic syndrome 0.4752589577030091 1.0916930705132846 0.2749680320068326 1.0 0.8414318080235993 14 O75844,Q9BT22,Q7Z4L5 3 |
| Nonhomologous end joining 0.6731496428334152 1.0858212452120328 0.2775580851109183 1.0 0.8414318080235993 4 Q13426 1 |
| Mapk cascade 0.5674489889934017 1.0672588621999552 0.2858549589634296 1.0 0.8414318080235993 7 P62993,P36507,P27361,Q16539 4 |
| Camkk2 pathway 0.4703821356349993 1.06208905928392 0.2881952564254684 1.0 0.8414318080235993 14 P09601 1 |
| 3q29 copy number variation syndrome 0.4654899012046816 1.0615368291602028 0.2884460048477715 1.0 0.8414318080235993 15 P61088,O94888,O95684,Q96EB6,P49585 5 |
| Nad metabolism 0.8045017720585343 1.0048386818560209 0.3149745343543579 1.0 0.8827140538577976 3 P43490 1 |
| Alzheimers disease 0.3476753983043786 0.9962152210253238 0.3191455853981257 1.0 0.8827140538577976 92 P28070,Q9NSK0,P45880,P60900,P68400,P28072,O95197,Q99436,P0DP25,P28074,Q9NQC3,P49721,P21796,P05067,P25787,P20618 16 |
| Alzheimers disease and mirna effects 0.3469939376661442 0.995069748248336 0.3197023426908012 1.0 0.8827140538577976 93 P28070,Q9NSK0,P45880,P60900,P68400,P28072,O95197,Q99436,P0DP25,P28074,Q9NQC3,P49721,P21796,P05067,P25787,P20618 16 |
| Cannabinoid receptor signaling 0.571105711261194 0.979701185569247 0.3272336407270364 1.0 0.8867447317915674 6 Q8NCG7,P27361,P28482,Q16539 4 |
| Nanoparticlemediated activation of receptor signaling 0.5453384387527019 0.9634282382412792 0.3353326609149607 1.0 0.9006501113954918 7 P62993,P36507,Q16539 3 |
| Thermogenesis 0.3954855454181204 0.9465716017811882 0.3438571203907155 1.0 0.906007130188128 28 P23786,O43772,P51812 3 |
| Urea cycle and related diseases 0.7840483731644183 0.9447428150644008 0.344790192872253 1.0 0.906007130188128 2 Q9Y619 1 |
| Inclusion body myositis 0.7825160457736988 0.9244918555988372 0.3552302899130353 1.0 0.9175941361646044 3 P05067 1 |
| Spinal cord injury 0.4092602030647904 0.8992489141461842 0.3685200915165758 1.0 0.9175941361646044 22 P11802,P06493,Q9NQC3,P08670,P62942 5 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.6244060029285445 0.8877256365169858 0.3746883522488144 1.0 0.9175941361646044 4 P36507,P27361 2 |
| Serotonin receptor 467 and nr3c signaling 0.6244060029285445 0.8877256365169858 0.3746883522488144 1.0 0.9175941361646044 4 P36507,P27361 2 |
| Kit receptor signaling pathway 0.4230421151502676 0.8803407424998403 0.3786747474954246 1.0 0.9175941361646044 18 P36507,Q15418,P62993,P46108,P51812 5 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.6216348089773457 0.8766078574618638 0.3806996698780573 1.0 0.9175941361646044 4 P27361,P08670 2 |
| Interleukin1 induced activation of nfkb 0.7618773394759608 0.8593196929968804 0.3901641622459701 1.0 0.9175941361646044 2 P61088 1 |
| G1 to s cell cycle control 0.4004169797712796 0.8587190034797191 0.3904955634419167 1.0 0.9175941361646044 23 P33991,P11802,P06493,Q9Y619,P49736,Q14566,P25205 7 |
| Mitochondrial long chain fatty acid betaoxidation 0.4291785615998704 0.8366267956888396 0.4028023788728485 1.0 0.9254731230098237 15 P23786,Q16836,O43772 3 |
| 15q112 copy number variation syndrome 0.7567259391582044 0.8317296985894812 0.4055615333123774 1.0 0.9254731230098237 3 Q9BSJ2 1 |
| Pregnane x receptor pathway 0.534516844943873 0.8166879839242605 0.4141067599259254 1.0 0.9329392045737273 6 Q06520,P07900,P08183 3 |
| Neovascularisation processes 0.7454650158364517 0.7972619786154299 0.4252988971821483 1.0 0.9329392045737273 2 P27361 1 |
| Dna repair pathways full network 0.3428871514858524 0.794587690025956 0.4268533813477755 1.0 0.9329392045737273 51 P54727,P41440,Q9NRF9,P18074,P13051,Q9NR33,P41208,P54725 8 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.4370104038819584 0.7660073768758585 0.4436719128486732 1.0 0.9329392045737273 12 P13674 1 |
| Melatonin metabolism and effects 0.7362350918253331 0.7594877049512773 0.4475608661897241 1.0 0.9329392045737273 3 P42892 1 |
| Mevalonate arm of cholesterol biosynthesis pathway 0.4420651466373649 0.7307019293772077 0.4649612368294793 1.0 0.935628103874384 11 Q01581,Q9BWD1 2 |
| Regulatory circuits of the stat3 signaling pathway 0.4636317792614921 0.7134909607962585 0.4755420045939063 1.0 0.935628103874384 9 P27361,P16949,Q8WTS6,P28482,Q16539 5 |
| Interactions between loxl4 and oxidative stress pathway 0.5798080596260863 0.7117847908222941 0.4765980522295607 1.0 0.935628103874384 4 Q96EB6 1 |
| Genes related to primary cilium development based on crispr 0.4005668737226835 0.6840236734906049 0.4939602170343791 1.0 0.935628103874384 16 Q7Z4L5,A0AVF1,Q86SX3,O95684 4 |
| Angiogenesis 0.7035655240843729 0.6477467863530245 0.5171487381751505 1.0 0.9435781429206328 3 Q16539 1 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.3975013460146336 0.642551465219253 0.5205151846587599 1.0 0.9435781429206328 15 O95433,P62993,P11802 3 |
| Cytoplasmic ribosomal proteins 0.3222274336259209 0.6413485782545614 0.5212962340954692 1.0 0.9435781429206328 74 P62750,P05387,P62847,P61927,Q15418,P62841,P46778,Q9Y3U8,P83881,P61254,P39019,P62081,P62899,P23396,P46782,P51812,P42766,P61353,P62851,P62861,P08865,P61513,P62917,P62277,P46783 25 |
| P38 mapk signaling pathway 0.4597453063857456 0.6296720736306929 0.528909157450342 1.0 0.949817850606175 8 P62993,P05114 2 |
| Angiopoietinlike protein 8 regulatory pathway 0.3485271302541555 0.6218259455995269 0.5340563238048528 1.0 0.9505698050110928 30 P41440,P36507,P13807,P11166,Q15418,P46108,P54619,Q9UPT5,P51812,Q16539 10 |
| Farnesoid x receptor pathway 0.6965159804203938 0.6200353390638851 0.5352345210868126 1.0 0.9505698050110928 2 Q06520 1 |
| Monoamine transport 0.4863344313551088 0.6085030026567918 0.5428539150997722 1.0 0.9522648506470662 6 P49418,O15127 2 |
| Acetylcholine synthesis 0.689642043132606 0.6016792609565266 0.5473876575051504 1.0 0.9522648506470662 3 P35790 1 |
| Neuroinflammation 0.5493237904532455 0.5964696800588997 0.5508615031051358 1.0 0.9522648506470662 4 P00403 1 |
| Base excision repair 0.3776637741744447 0.5845214627402212 0.5588695296123385 1.0 0.9522648506470662 18 Q9NR33,Q9NRF9 2 |
| Ebsteinbarr virus lmp1 signaling 0.5406819290599844 0.5647592836001568 0.5722375048043526 1.0 0.9522648506470662 4 Q9NR12,P07900 2 |
| Proximal tubule transport 0.3891394436912973 0.5573934452457808 0.577258642938562 1.0 0.9522648506470662 13 P04920,P11166,Q9Y5K8,P08183,O75348 5 |
| Sulfation biotransformation reaction 0.489739944659624 0.5573474931222115 0.5772900325750365 1.0 0.9522648506470662 5 O95340 1 |
| Estrogen receptor pathway 0.6625652467277174 0.5153132631781218 0.6063341322351494 1.0 0.9522648506470662 3 Q15067 1 |
| Histone modifications 0.4110169521972727 0.4606894114735226 0.6450214528279465 1.0 0.9684688129369668 9 Q01105 1 |
| Statin inhibition of cholesterol production 0.4453744032963906 0.442181531276194 0.6583578494950835 1.0 0.9684688129369668 6 Q8WTV0 1 |
| Complement system in neuronal development and plasticity 0.3947736550968352 0.4372661616583476 0.6619183326648712 1.0 0.9684688129369668 10 Q9NR28 1 |
| Fatty acid betaoxidation 0.3449195410219799 0.4371008918910716 0.662038180514724 1.0 0.9684688129369668 21 P23786,O43772 2 |
| Amyotrophic lateral sclerosis als 0.3860627365996468 0.4367383959046587 0.6623010802323293 1.0 0.9684688129369668 11 P07196,P36507,Q9BUN8,Q16539 4 |
| Epo receptor signaling 0.413653702570941 0.4227034838626166 0.6725116134430662 1.0 0.9684688129369668 8 P62993,P36507,P27361 3 |
| Mapk pathway in congenital thyroid cancer 0.6258615912861769 0.4063714128096334 0.6844697211696191 1.0 0.9684688129369668 3 P36507 1 |
| Drug induction of bile acid pathway 0.6242323011886307 0.4017832164219033 0.687843575059047 1.0 0.9693673894413822 3 P08183 1 |
| Methionine de novo and salvage pathway 0.3906998118736227 0.3692491120084986 0.7119420521923552 1.0 0.9733081659476568 9 Q13126 1 |
| Glycerolipids and glycerophospholipids 0.4087360856989935 0.3607451367781484 0.7182899792594228 1.0 0.9743951997214714 7 Q9UG56,P49585 2 |
| Fgfr3 signaling in chondrocyte proliferation and terminal differentiation 0.4050546108869666 0.3464737833377888 0.7289866833940093 1.0 0.9761174745742124 7 P36507,P27361,Q16539 3 |
| Relationship between inflammation cox2 and egfr 0.4683627505246494 0.3232202101906318 0.7465284761564115 1.0 0.9761174745742124 4 Q9H7Z7,P27361 2 |
| Mitochondrial immune response to sarscov2 0.3751350697406979 0.3025405782344239 0.7622400048569633 1.0 0.9761174745742124 9 Q9Y6M9 1 |
| Caloric restriction and aging 0.4584619682019374 0.2942995008435973 0.7685290540414493 1.0 0.9776616353839052 4 P43490 1 |
| Ciliary landscape 0.2731344642646115 0.2931637325627011 0.7693970040049904 1.0 0.9776616353839052 120 O95721,P07196,P52565,P08670,O95400,P09669,O43464,Q9Y4Z0,P33992,Q9BT78,Q99627,P51665,O15173,Q8IVV7,O75663,Q92600,Q9NWU2,P33991,Q96A65,Q9UNS2,A0AVF1,Q96P70,Q9Y6G9,O60645,Q9NQ48,P07197,Q14566,Q15555,Q96KP1,Q9Y266,Q9Y4W6,O43805,Q13409,Q9UPT5,Q15051,P61201,P49736,P25205,Q9UBW8,Q9H9Q2 40 |
| Pdgfrbeta pathway 0.390138408304493 0.2904146334646814 0.7714990499981724 1.0 0.9776616353839052 7 P27361,P40763,P62993,Q02750,P19525,P19174 6 |
| Translation inhibitors in chronically activated pdgfra cells 0.3268579570569861 0.2861491837593972 0.7747638625154214 1.0 0.9797364421966008 19 Q14240,P68400,P36507,Q15418,Q16539,P23588 6 |
| Nad biosynthetic pathways 0.4491682288674777 0.2682434419020535 0.7885119380410808 1.0 0.9845092529796644 4 P43490 1 |
| Triacylglyceride synthesis 0.40594127764295 0.2610943275439075 0.7940197659730774 1.0 0.985372957186698 5 O00116,Q9NUQ2 2 |
| Rac1pak1p38mmp2 pathway 0.3263453728152879 0.2456631569464667 0.8059429947759265 1.0 0.99432397932721 16 P27361,P16949,P62993,P46108,Q16539 5 |
| Vitamin d receptor pathway 0.3427448591526296 0.2316339569961732 0.8168223308294462 1.0 0.9982683105002432 11 Q96KA5,P08183 2 |
| Osteopontin signaling 0.3893371757924979 0.2125032513376234 0.8317144415063185 1.0 1.0 5 P28482,P27361,P06756,Q02750 4 |
| Regulation of actin cytoskeleton 0.2885734000240773 0.2050294005172179 0.8375491546487694 1.0 1.0 44 Q9UQB8,Q92888,P26038,P36507,Q14185,P35241,P46108,Q96F07,P15311 9 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.537718840609801 0.195124171666437 0.8452957400062124 1.0 1.0 3 P27361 1 |
| Disruption of postsynaptic signaling by cnv 0.3476853315725783 0.1937118711409295 0.8464014960870638 1.0 1.0 9 P27361,Q06787,P28482 3 |
| Hypothesized pathways in pathogenesis of cardiovascular disease 0.4189863000410653 0.1914911553784673 0.8481408093128406 1.0 1.0 4 P27361,Q16539 2 |
| Folate metabolism 0.3170398402214909 0.1884241553449477 0.8505441655922963 1.0 1.0 15 Q8WTV0,P41440 2 |
| Mapk signaling pathway 0.2875684511683889 0.1804403319986097 0.8568068935636353 1.0 1.0 36 P46108,Q9Y4G8,P51812 3 |
| 16p112 distal deletion syndrome 0.3485720749734916 0.1711293859138494 0.8641220300653767 1.0 1.0 8 P62993,Q8NCF5 2 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.309578007513302 0.1470706867159019 0.8830762268629981 1.0 1.0 14 P17096,P43490,Q96EB6 3 |
| Molybdenum cofactor moco biosynthesis 0.5122372588540163 0.1437363617104451 0.8857086568346282 1.0 1.0 2 Q9NZB8 1 |
| Id signaling pathway 0.509069968327099 0.1390981163141408 0.8893726167203182 1.0 1.0 2 P24941 1 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3016785838776396 0.1335867082046805 0.893729395290914 1.0 1.0 18 P62993,Q14739,P50402 3 |
| Tnfalpha signaling pathway 0.2965434839871123 0.1154441257712532 0.9080931054321686 1.0 1.0 19 P27361,P07900,P68400,Q16543,P62993,P28482,P06737,Q9NR28 8 |
| Il9 signaling pathway 0.3250560203016498 0.1142237012659803 0.9090604639743798 1.0 1.0 9 P62993,P36507,P27361 3 |
| Liver x receptor pathway 0.4848833861215182 0.1078035928617208 0.9141514928110788 1.0 1.0 2 P49327 1 |
| Melanoma 0.2938786362792803 0.0937573213069004 0.9253019349481866 1.0 1.0 18 P36507,P11802,P0DP25,P62993,P18206 5 |
| Gpr40 pathway 0.4627123524330644 0.0852022108492496 0.9321006329713024 1.0 1.0 2 P19174 1 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.3303065956394345 0.0803424777940173 0.9359648749916734 1.0 1.0 6 P36507,P27361 2 |
| Hepatocyte growth factor receptor signaling 0.2916637750057387 0.0679800385019019 0.9458015244872584 1.0 1.0 13 P46108,P62993,Q14185 3 |
| Leptininsulin signaling overlap 0.4391016412323775 0.0668830032223536 0.9466748442003066 1.0 1.0 2 O14654 1 |
| Arrhythmogenic right ventricular cardiomyopathy 0.2906674371568824 0.0637728303739726 0.949151112429396 1.0 1.0 14 P14923,P06756,P02545,P16615,P05556,O43707,P35221,P50402,Q14126,P15924,P12814,P19022,P23229 13 |
| Bdnftrkb signaling 0.3103962587573073 0.0575427023151518 0.954112890911972 1.0 1.0 8 Q15418 1 |
| Calcium regulation in cardiac cells 0.2746516851233199 0.0456300082831211 0.9636051509246109 1.0 1.0 26 P0DP25,P62258,P62942 3 |
| Physiological and pathological hypertrophy of the heart 0.3127423451797919 0.0444609878905468 0.9645369483607458 1.0 1.0 6 Q9P2K5,Q16539 2 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.3890008638065022 0.0437046431500749 0.965139838056618 1.0 1.0 2 P28482 1 |
| Complement and coagulation cascades 0.3820904117477621 0.0417976499614841 0.9666600084365842 1.0 1.0 2 P49257 1 |
| Metapathway biotransformation phase i and ii 0.2744504432621486 0.0368151028577015 0.9706324318729844 1.0 1.0 25 Q86UY6,Q8NCH0,Q7LGA3,P07099,Q16850,P78417,Q6UW02,Q06520 8 |
| Omega3 omega6 fatty acid synthesis 0.3029065484428176 0.0269001367373062 0.9785393844573408 1.0 1.0 6 Q15067 1 |
| Burn wound healing 0.2942609659310222 0.0237020725809659 0.981090252790809 1.0 1.0 9 P09429,P08670 2 |
| Sudden infant death syndrome sids susceptibility pathways 0.2663674794588105 0.0192579934410452 0.9846352940860948 1.0 1.0 30 P42892 1 |
| Retinoblastoma gene in cancer 0.2637295438915935 0.0118699420900176 0.9905293788639628 1.0 1.0 47 P00374,P33991,P11802,P06493,P16949,Q9Y619,Q16204,P26583 8 |
| Methylation pathways 0.2906943244021954 0.0111888461106399 0.9910727787023949 1.0 1.0 4 Q9NZL9,P21964,P31153 3 |
|
|
